The shares of Celgene Corporation (NASDAQ:CELG) has been pegged with a rating of Equal Weight by Barclays in its latest research note that was published on May 3rd, 2019. The research company has also assigned a $102 price target. Barclays wasn’t the only research firm that published a report of Celgene Corporation, with other equities research analysts also giving their opinion on the stock. William Blair advised investors in its research note published on April 1st, 2019, to Mkt Perform the CELG stock. The stock had earned Neutral rating from UBS when it published its report on April 1st, 2019. That day the UBS set price target on the stock to $102. The stock was given Neutral rating by Atlantic Equities in its report released on April 1st, 2019. Jefferies was of a view that CELG is Hold in its latest report on February 1st, 2019 while giving it a price target of $95. Robert W. Baird thinks that CELG is worth Outperform rating. This was contained in the firm’s report on January 4th, 2019.

Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 19 believe it has the potential for further growth, thus rating it as Hold while 1 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $97.00. The price of the stock the last time has raised by 64.81% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 58.85.

The shares of the company added by 0.61% during the trading session on Wednesday, reaching a low of $95.96 while ending the day at $96.56. During the trading session, a total of 3.77 million shares were traded which represents a 47.99% incline from the average session volume which is 7.25M shares. CELG had ended its last session trading at 95.97. Celgene Corporation currently has a market cap of $67.50B, while its P/E ratio stands at 14.68, while its P/E earnings growth sits at 4.28, with a beta of 1.54. Celgene Corporation debt-to-equity ratio currently stands at 2.48, while its quick ratio hovers at 2.70. CELG 52-week low price stands at $58.59 while its 52-week high price is $97.07.

The company in its last quarterly report recorded $2.55 earnings per share which is above the $2.43 predicted by most analysts. The Celgene Corporation generated $4,025.00 million in revenue during the last quarter, which is slightly higher than the $4,008.61 million predicted by analysts. In the second quarter last year, the firm recorded $2.39 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 6.27%. Celgene Corporation has the potential to record 6.58 EPS for the current fiscal year, according to equities analysts.

Investment analysts at Pivotal Research Group published a research note on May 29th, 2019 where it informed investors and clients that Pinterest, Inc. (NYSE:PINS) is now rated as Hold. William Blair also rated PINS as Downgrade on April 1st, 2019, with its price target of $121 suggesting that PINS could surge by 3.29% from its current share price. Even though the stock has been trading at $26.48/share, analysts expect it to surge higher by 2.15% to reach $27.97/share. It started the day trading at $27.50 and traded between $26.21 and $27.05 throughout the trading session.

At the moment, only of Pinterest, Inc. shares were sold short. The company’s average trading volume currently stands at 11.98M shares, which means that the short-interest ratio is just 0.43 days. Over the past seven days, the company moved, with its shift of 8.46%. Looking further, the stock has dropped over the past 90 days while it lost over the last six months.

Renaissance Capital LLC meanwhile bought more PINS shares in the recently filed quarter, changing its stake to $521,177 worth of shares.